nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2C18—Diphenhydramine—atopic dermatitis	0.0962	0.125	CbGbCtD
Cyclophosphamide—CYP3A7—Tacrolimus—atopic dermatitis	0.0437	0.0568	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0437	0.0568	CbGbCtD
Cyclophosphamide—CYP2C8—Mometasone—atopic dermatitis	0.0401	0.0522	CbGbCtD
Cyclophosphamide—CYP3A5—Tacrolimus—atopic dermatitis	0.0328	0.0426	CbGbCtD
Cyclophosphamide—CYP2B6—Diphenhydramine—atopic dermatitis	0.0304	0.0396	CbGbCtD
Cyclophosphamide—CYP2A6—Prednisolone—atopic dermatitis	0.0274	0.0357	CbGbCtD
Cyclophosphamide—CYP2C8—Loratadine—atopic dermatitis	0.0231	0.03	CbGbCtD
Cyclophosphamide—CYP3A4—Pimecrolimus—atopic dermatitis	0.0215	0.028	CbGbCtD
Cyclophosphamide—ABCB1—Tacrolimus—atopic dermatitis	0.0213	0.0277	CbGbCtD
Cyclophosphamide—CYP2C19—Diphenhydramine—atopic dermatitis	0.0193	0.0252	CbGbCtD
Cyclophosphamide—CYP2C19—Loratadine—atopic dermatitis	0.0193	0.0252	CbGbCtD
Cyclophosphamide—CYP3A7—Hydrocortisone—atopic dermatitis	0.0178	0.0231	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0178	0.0231	CbGbCtD
Cyclophosphamide—CYP2A6—Dexamethasone—atopic dermatitis	0.0162	0.0211	CbGbCtD
Cyclophosphamide—CYP2C9—Loratadine—atopic dermatitis	0.0161	0.0209	CbGbCtD
Cyclophosphamide—CYP2C9—Diphenhydramine—atopic dermatitis	0.0161	0.0209	CbGbCtD
Cyclophosphamide—ABCB1—Loratadine—atopic dermatitis	0.0156	0.0203	CbGbCtD
Cyclophosphamide—CYP2D6—Loratadine—atopic dermatitis	0.0147	0.0191	CbGbCtD
Cyclophosphamide—CYP2D6—Diphenhydramine—atopic dermatitis	0.0147	0.0191	CbGbCtD
Cyclophosphamide—ABCB1—Methylprednisolone—atopic dermatitis	0.0143	0.0186	CbGbCtD
Cyclophosphamide—CYP3A5—Hydrocortisone—atopic dermatitis	0.0133	0.0174	CbGbCtD
Cyclophosphamide—CYP2C8—Hydrocortisone—atopic dermatitis	0.0128	0.0167	CbGbCtD
Cyclophosphamide—CYP3A4—Tacrolimus—atopic dermatitis	0.0128	0.0166	CbGbCtD
Cyclophosphamide—CYP3A7—Dexamethasone—atopic dermatitis	0.0111	0.0144	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.0111	0.0144	CbGbCtD
Cyclophosphamide—CYP2C19—Prednisone—atopic dermatitis	0.0107	0.0139	CbGbCtD
Cyclophosphamide—CYP2B6—Dexamethasone—atopic dermatitis	0.0105	0.0137	CbGbCtD
Cyclophosphamide—CYP3A4—Loratadine—atopic dermatitis	0.00935	0.0122	CbGbCtD
Cyclophosphamide—ABCB1—Betamethasone—atopic dermatitis	0.00928	0.0121	CbGbCtD
Cyclophosphamide—ABCB1—Prednisolone—atopic dermatitis	0.00916	0.0119	CbGbCtD
Cyclophosphamide—ABCB1—Hydrocortisone—atopic dermatitis	0.00868	0.0113	CbGbCtD
Cyclophosphamide—ABCB1—Prednisone—atopic dermatitis	0.00865	0.0113	CbGbCtD
Cyclophosphamide—CYP3A4—Methylprednisolone—atopic dermatitis	0.00855	0.0111	CbGbCtD
Cyclophosphamide—CYP3A5—Dexamethasone—atopic dermatitis	0.00829	0.0108	CbGbCtD
Cyclophosphamide—CYP2C8—Dexamethasone—atopic dermatitis	0.00798	0.0104	CbGbCtD
Cyclophosphamide—CYP2C19—Dexamethasone—atopic dermatitis	0.00669	0.00871	CbGbCtD
Cyclophosphamide—CYP3A4—Triamcinolone—atopic dermatitis	0.00648	0.00844	CbGbCtD
Cyclophosphamide—CYP2C9—Dexamethasone—atopic dermatitis	0.00556	0.00724	CbGbCtD
Cyclophosphamide—CYP3A4—Betamethasone—atopic dermatitis	0.00556	0.00724	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisolone—atopic dermatitis	0.00549	0.00714	CbGbCtD
Cyclophosphamide—ABCB1—Dexamethasone—atopic dermatitis	0.0054	0.00703	CbGbCtD
Cyclophosphamide—CYP3A4—Hydrocortisone—atopic dermatitis	0.0052	0.00677	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisone—atopic dermatitis	0.00518	0.00674	CbGbCtD
Cyclophosphamide—CYP2D6—Dexamethasone—atopic dermatitis	0.00509	0.00662	CbGbCtD
Cyclophosphamide—CYP3A4—Dexamethasone—atopic dermatitis	0.00323	0.00421	CbGbCtD
Cyclophosphamide—Haemoglobin—Betamethasone—atopic dermatitis	9.65e-05	0.000417	CcSEcCtD
Cyclophosphamide—Haemorrhage—Dexamethasone—atopic dermatitis	9.6e-05	0.000415	CcSEcCtD
Cyclophosphamide—Haemorrhage—Betamethasone—atopic dermatitis	9.6e-05	0.000415	CcSEcCtD
Cyclophosphamide—Nausea—Mometasone—atopic dermatitis	9.55e-05	0.000412	CcSEcCtD
Cyclophosphamide—Weight increased—Prednisone—atopic dermatitis	9.51e-05	0.00041	CcSEcCtD
Cyclophosphamide—Arrhythmia—Triamcinolone—atopic dermatitis	9.46e-05	0.000408	CcSEcCtD
Cyclophosphamide—Vision blurred—Prednisolone—atopic dermatitis	9.44e-05	0.000408	CcSEcCtD
Cyclophosphamide—Arrhythmia—Methylprednisolone—atopic dermatitis	9.43e-05	0.000407	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Tacrolimus—atopic dermatitis	9.43e-05	0.000407	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Prednisone—atopic dermatitis	9.43e-05	0.000407	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Prednisolone—atopic dermatitis	9.3e-05	0.000401	CcSEcCtD
Cyclophosphamide—Visual impairment—Dexamethasone—atopic dermatitis	9.25e-05	0.000399	CcSEcCtD
Cyclophosphamide—Visual impairment—Betamethasone—atopic dermatitis	9.25e-05	0.000399	CcSEcCtD
Cyclophosphamide—Erythema—Triamcinolone—atopic dermatitis	9.21e-05	0.000398	CcSEcCtD
Cyclophosphamide—Erythema—Methylprednisolone—atopic dermatitis	9.19e-05	0.000397	CcSEcCtD
Cyclophosphamide—Asthenia—Tacrolimus—atopic dermatitis	9.18e-05	0.000396	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Prednisone—atopic dermatitis	9.18e-05	0.000396	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Prednisone—atopic dermatitis	9.13e-05	0.000394	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Prednisone—atopic dermatitis	9.13e-05	0.000394	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Hydrocortisone—atopic dermatitis	9.08e-05	0.000392	CcSEcCtD
Cyclophosphamide—Pruritus—Tacrolimus—atopic dermatitis	9.06e-05	0.000391	CcSEcCtD
Cyclophosphamide—Malaise—Prednisolone—atopic dermatitis	9.03e-05	0.00039	CcSEcCtD
Cyclophosphamide—Dysgeusia—Triamcinolone—atopic dermatitis	9.02e-05	0.000389	CcSEcCtD
Cyclophosphamide—Malaise—Hydrocortisone—atopic dermatitis	8.82e-05	0.000381	CcSEcCtD
Cyclophosphamide—Diarrhoea—Tacrolimus—atopic dermatitis	8.76e-05	0.000378	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisolone—atopic dermatitis	8.68e-05	0.000375	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisolone—atopic dermatitis	8.65e-05	0.000373	CcSEcCtD
Cyclophosphamide—Arrhythmia—Betamethasone—atopic dermatitis	8.58e-05	0.00037	CcSEcCtD
Cyclophosphamide—Arrhythmia—Dexamethasone—atopic dermatitis	8.58e-05	0.00037	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Triamcinolone—atopic dermatitis	8.55e-05	0.000369	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methylprednisolone—atopic dermatitis	8.53e-05	0.000368	CcSEcCtD
Cyclophosphamide—Bradycardia—Prednisone—atopic dermatitis	8.51e-05	0.000368	CcSEcCtD
Cyclophosphamide—Alopecia—Betamethasone—atopic dermatitis	8.49e-05	0.000366	CcSEcCtD
Cyclophosphamide—Alopecia—Dexamethasone—atopic dermatitis	8.49e-05	0.000366	CcSEcCtD
Cyclophosphamide—Convulsion—Hydrocortisone—atopic dermatitis	8.48e-05	0.000366	CcSEcCtD
Cyclophosphamide—Dizziness—Tacrolimus—atopic dermatitis	8.47e-05	0.000365	CcSEcCtD
Cyclophosphamide—Hypertension—Hydrocortisone—atopic dermatitis	8.45e-05	0.000365	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisolone—atopic dermatitis	8.43e-05	0.000364	CcSEcCtD
Cyclophosphamide—Haemoglobin—Prednisone—atopic dermatitis	8.41e-05	0.000363	CcSEcCtD
Cyclophosphamide—Haemorrhage—Prednisone—atopic dermatitis	8.36e-05	0.000361	CcSEcCtD
Cyclophosphamide—Erythema—Dexamethasone—atopic dermatitis	8.36e-05	0.000361	CcSEcCtD
Cyclophosphamide—Erythema—Betamethasone—atopic dermatitis	8.36e-05	0.000361	CcSEcCtD
Cyclophosphamide—Myalgia—Hydrocortisone—atopic dermatitis	8.33e-05	0.00036	CcSEcCtD
Cyclophosphamide—Malaise—Triamcinolone—atopic dermatitis	8.31e-05	0.000359	CcSEcCtD
Cyclophosphamide—Malaise—Methylprednisolone—atopic dermatitis	8.29e-05	0.000358	CcSEcCtD
Cyclophosphamide—Discomfort—Hydrocortisone—atopic dermatitis	8.23e-05	0.000355	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisolone—atopic dermatitis	8.18e-05	0.000353	CcSEcCtD
Cyclophosphamide—Oedema—Prednisolone—atopic dermatitis	8.18e-05	0.000353	CcSEcCtD
Cyclophosphamide—Vomiting—Tacrolimus—atopic dermatitis	8.14e-05	0.000351	CcSEcCtD
Cyclophosphamide—Rash—Tacrolimus—atopic dermatitis	8.07e-05	0.000348	CcSEcCtD
Cyclophosphamide—Dermatitis—Tacrolimus—atopic dermatitis	8.06e-05	0.000348	CcSEcCtD
Cyclophosphamide—Shock—Prednisolone—atopic dermatitis	8.04e-05	0.000347	CcSEcCtD
Cyclophosphamide—Cough—Triamcinolone—atopic dermatitis	8.04e-05	0.000347	CcSEcCtD
Cyclophosphamide—Headache—Tacrolimus—atopic dermatitis	8.02e-05	0.000346	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Hydrocortisone—atopic dermatitis	7.99e-05	0.000345	CcSEcCtD
Cyclophosphamide—Oedema—Hydrocortisone—atopic dermatitis	7.99e-05	0.000345	CcSEcCtD
Cyclophosphamide—Convulsion—Triamcinolone—atopic dermatitis	7.98e-05	0.000345	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisolone—atopic dermatitis	7.98e-05	0.000344	CcSEcCtD
Cyclophosphamide—Convulsion—Methylprednisolone—atopic dermatitis	7.97e-05	0.000344	CcSEcCtD
Cyclophosphamide—Hypertension—Triamcinolone—atopic dermatitis	7.95e-05	0.000343	CcSEcCtD
Cyclophosphamide—Hypertension—Methylprednisolone—atopic dermatitis	7.94e-05	0.000343	CcSEcCtD
Cyclophosphamide—Infection—Hydrocortisone—atopic dermatitis	7.93e-05	0.000342	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisolone—atopic dermatitis	7.9e-05	0.000341	CcSEcCtD
Cyclophosphamide—Shock—Hydrocortisone—atopic dermatitis	7.86e-05	0.000339	CcSEcCtD
Cyclophosphamide—Myalgia—Triamcinolone—atopic dermatitis	7.84e-05	0.000339	CcSEcCtD
Cyclophosphamide—Myalgia—Methylprednisolone—atopic dermatitis	7.83e-05	0.000338	CcSEcCtD
Cyclophosphamide—Arthralgia—Methylprednisolone—atopic dermatitis	7.83e-05	0.000338	CcSEcCtD
Cyclophosphamide—Tachycardia—Hydrocortisone—atopic dermatitis	7.79e-05	0.000336	CcSEcCtD
Cyclophosphamide—Flushing—Prednisone—atopic dermatitis	7.76e-05	0.000335	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Betamethasone—atopic dermatitis	7.76e-05	0.000335	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Dexamethasone—atopic dermatitis	7.76e-05	0.000335	CcSEcCtD
Cyclophosphamide—Discomfort—Triamcinolone—atopic dermatitis	7.75e-05	0.000335	CcSEcCtD
Cyclophosphamide—Discomfort—Methylprednisolone—atopic dermatitis	7.73e-05	0.000334	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Hydrocortisone—atopic dermatitis	7.72e-05	0.000333	CcSEcCtD
Cyclophosphamide—Anorexia—Hydrocortisone—atopic dermatitis	7.61e-05	0.000329	CcSEcCtD
Cyclophosphamide—Nausea—Tacrolimus—atopic dermatitis	7.6e-05	0.000328	CcSEcCtD
Cyclophosphamide—Confusional state—Methylprednisolone—atopic dermatitis	7.57e-05	0.000327	CcSEcCtD
Cyclophosphamide—Malaise—Betamethasone—atopic dermatitis	7.54e-05	0.000325	CcSEcCtD
Cyclophosphamide—Malaise—Dexamethasone—atopic dermatitis	7.54e-05	0.000325	CcSEcCtD
Cyclophosphamide—Oedema—Triamcinolone—atopic dermatitis	7.52e-05	0.000325	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Triamcinolone—atopic dermatitis	7.52e-05	0.000325	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methylprednisolone—atopic dermatitis	7.5e-05	0.000324	CcSEcCtD
Cyclophosphamide—Arrhythmia—Prednisone—atopic dermatitis	7.47e-05	0.000322	CcSEcCtD
Cyclophosphamide—Infection—Triamcinolone—atopic dermatitis	7.47e-05	0.000322	CcSEcCtD
Cyclophosphamide—Hypotension—Hydrocortisone—atopic dermatitis	7.46e-05	0.000322	CcSEcCtD
Cyclophosphamide—Infection—Methylprednisolone—atopic dermatitis	7.45e-05	0.000322	CcSEcCtD
Cyclophosphamide—Shock—Triamcinolone—atopic dermatitis	7.4e-05	0.000319	CcSEcCtD
Cyclophosphamide—Alopecia—Prednisone—atopic dermatitis	7.39e-05	0.000319	CcSEcCtD
Cyclophosphamide—Shock—Methylprednisolone—atopic dermatitis	7.38e-05	0.000319	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisolone—atopic dermatitis	7.34e-05	0.000317	CcSEcCtD
Cyclophosphamide—Tachycardia—Triamcinolone—atopic dermatitis	7.34e-05	0.000317	CcSEcCtD
Cyclophosphamide—Tachycardia—Methylprednisolone—atopic dermatitis	7.32e-05	0.000316	CcSEcCtD
Cyclophosphamide—Erythema—Prednisone—atopic dermatitis	7.28e-05	0.000314	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	7.28e-05	0.000314	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Triamcinolone—atopic dermatitis	7.27e-05	0.000314	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methylprednisolone—atopic dermatitis	7.25e-05	0.000313	CcSEcCtD
Cyclophosphamide—Convulsion—Betamethasone—atopic dermatitis	7.24e-05	0.000313	CcSEcCtD
Cyclophosphamide—Convulsion—Dexamethasone—atopic dermatitis	7.24e-05	0.000313	CcSEcCtD
Cyclophosphamide—Hypertension—Betamethasone—atopic dermatitis	7.22e-05	0.000312	CcSEcCtD
Cyclophosphamide—Hypertension—Dexamethasone—atopic dermatitis	7.22e-05	0.000312	CcSEcCtD
Cyclophosphamide—Paraesthesia—Hydrocortisone—atopic dermatitis	7.17e-05	0.00031	CcSEcCtD
Cyclophosphamide—Myalgia—Betamethasone—atopic dermatitis	7.12e-05	0.000307	CcSEcCtD
Cyclophosphamide—Myalgia—Dexamethasone—atopic dermatitis	7.12e-05	0.000307	CcSEcCtD
Cyclophosphamide—Discomfort—Dexamethasone—atopic dermatitis	7.03e-05	0.000304	CcSEcCtD
Cyclophosphamide—Discomfort—Betamethasone—atopic dermatitis	7.03e-05	0.000304	CcSEcCtD
Cyclophosphamide—Hypotension—Methylprednisolone—atopic dermatitis	7.01e-05	0.000303	CcSEcCtD
Cyclophosphamide—Pain—Prednisolone—atopic dermatitis	6.99e-05	0.000302	CcSEcCtD
Cyclophosphamide—Decreased appetite—Hydrocortisone—atopic dermatitis	6.94e-05	0.0003	CcSEcCtD
Cyclophosphamide—Fatigue—Hydrocortisone—atopic dermatitis	6.89e-05	0.000297	CcSEcCtD
Cyclophosphamide—Vision blurred—Prednisone—atopic dermatitis	6.86e-05	0.000296	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	6.85e-05	0.000296	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	6.84e-05	0.000295	CcSEcCtD
Cyclophosphamide—Pain—Hydrocortisone—atopic dermatitis	6.83e-05	0.000295	CcSEcCtD
Cyclophosphamide—Oedema—Dexamethasone—atopic dermatitis	6.82e-05	0.000295	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Dexamethasone—atopic dermatitis	6.82e-05	0.000295	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Betamethasone—atopic dermatitis	6.82e-05	0.000295	CcSEcCtD
Cyclophosphamide—Oedema—Betamethasone—atopic dermatitis	6.82e-05	0.000295	CcSEcCtD
Cyclophosphamide—Infection—Dexamethasone—atopic dermatitis	6.78e-05	0.000293	CcSEcCtD
Cyclophosphamide—Infection—Betamethasone—atopic dermatitis	6.78e-05	0.000293	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Prednisone—atopic dermatitis	6.76e-05	0.000292	CcSEcCtD
Cyclophosphamide—Paraesthesia—Triamcinolone—atopic dermatitis	6.75e-05	0.000291	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisolone—atopic dermatitis	6.74e-05	0.000291	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methylprednisolone—atopic dermatitis	6.74e-05	0.000291	CcSEcCtD
Cyclophosphamide—Anaemia—Prednisone—atopic dermatitis	6.73e-05	0.00029	CcSEcCtD
Cyclophosphamide—Shock—Betamethasone—atopic dermatitis	6.71e-05	0.00029	CcSEcCtD
Cyclophosphamide—Shock—Dexamethasone—atopic dermatitis	6.71e-05	0.00029	CcSEcCtD
Cyclophosphamide—Dyspnoea—Triamcinolone—atopic dermatitis	6.7e-05	0.000289	CcSEcCtD
Cyclophosphamide—Agitation—Prednisone—atopic dermatitis	6.69e-05	0.000289	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Dexamethasone—atopic dermatitis	6.68e-05	0.000288	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Betamethasone—atopic dermatitis	6.68e-05	0.000288	CcSEcCtD
Cyclophosphamide—Tachycardia—Dexamethasone—atopic dermatitis	6.66e-05	0.000287	CcSEcCtD
Cyclophosphamide—Tachycardia—Betamethasone—atopic dermatitis	6.66e-05	0.000287	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Dexamethasone—atopic dermatitis	6.6e-05	0.000285	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Betamethasone—atopic dermatitis	6.6e-05	0.000285	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Hydrocortisone—atopic dermatitis	6.58e-05	0.000284	CcSEcCtD
Cyclophosphamide—Malaise—Prednisone—atopic dermatitis	6.57e-05	0.000283	CcSEcCtD
Cyclophosphamide—Anorexia—Betamethasone—atopic dermatitis	6.5e-05	0.000281	CcSEcCtD
Cyclophosphamide—Anorexia—Dexamethasone—atopic dermatitis	6.5e-05	0.000281	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisolone—atopic dermatitis	6.5e-05	0.00028	CcSEcCtD
Cyclophosphamide—Fatigue—Triamcinolone—atopic dermatitis	6.48e-05	0.00028	CcSEcCtD
Cyclophosphamide—Fatigue—Methylprednisolone—atopic dermatitis	6.47e-05	0.000279	CcSEcCtD
Cyclophosphamide—Pain—Triamcinolone—atopic dermatitis	6.43e-05	0.000278	CcSEcCtD
Cyclophosphamide—Hypotension—Betamethasone—atopic dermatitis	6.38e-05	0.000275	CcSEcCtD
Cyclophosphamide—Hypotension—Dexamethasone—atopic dermatitis	6.38e-05	0.000275	CcSEcCtD
Cyclophosphamide—Urticaria—Hydrocortisone—atopic dermatitis	6.34e-05	0.000274	CcSEcCtD
Cyclophosphamide—Body temperature increased—Hydrocortisone—atopic dermatitis	6.31e-05	0.000272	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisone—atopic dermatitis	6.31e-05	0.000272	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisone—atopic dermatitis	6.29e-05	0.000271	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	6.22e-05	0.000268	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	6.22e-05	0.000268	CcSEcCtD
Cyclophosphamide—Arthralgia—Prednisone—atopic dermatitis	6.2e-05	0.000268	CcSEcCtD
Cyclophosphamide—Myalgia—Prednisone—atopic dermatitis	6.2e-05	0.000268	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Triamcinolone—atopic dermatitis	6.2e-05	0.000267	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Methylprednisolone—atopic dermatitis	6.18e-05	0.000267	CcSEcCtD
Cyclophosphamide—Paraesthesia—Betamethasone—atopic dermatitis	6.13e-05	0.000264	CcSEcCtD
Cyclophosphamide—Paraesthesia—Dexamethasone—atopic dermatitis	6.13e-05	0.000264	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisone—atopic dermatitis	6.12e-05	0.000264	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisolone—atopic dermatitis	6.02e-05	0.00026	CcSEcCtD
Cyclophosphamide—Urticaria—Triamcinolone—atopic dermatitis	5.97e-05	0.000258	CcSEcCtD
Cyclophosphamide—Urticaria—Methylprednisolone—atopic dermatitis	5.96e-05	0.000257	CcSEcCtD
Cyclophosphamide—Body temperature increased—Triamcinolone—atopic dermatitis	5.94e-05	0.000257	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisone—atopic dermatitis	5.94e-05	0.000256	CcSEcCtD
Cyclophosphamide—Oedema—Prednisone—atopic dermatitis	5.94e-05	0.000256	CcSEcCtD
Cyclophosphamide—Decreased appetite—Dexamethasone—atopic dermatitis	5.93e-05	0.000256	CcSEcCtD
Cyclophosphamide—Decreased appetite—Betamethasone—atopic dermatitis	5.93e-05	0.000256	CcSEcCtD
Cyclophosphamide—Infection—Prednisone—atopic dermatitis	5.9e-05	0.000255	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Hydrocortisone—atopic dermatitis	5.88e-05	0.000254	CcSEcCtD
Cyclophosphamide—Fatigue—Dexamethasone—atopic dermatitis	5.88e-05	0.000254	CcSEcCtD
Cyclophosphamide—Fatigue—Betamethasone—atopic dermatitis	5.88e-05	0.000254	CcSEcCtD
Cyclophosphamide—Shock—Prednisone—atopic dermatitis	5.85e-05	0.000252	CcSEcCtD
Cyclophosphamide—Pain—Dexamethasone—atopic dermatitis	5.83e-05	0.000252	CcSEcCtD
Cyclophosphamide—Pain—Betamethasone—atopic dermatitis	5.83e-05	0.000252	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisone—atopic dermatitis	5.8e-05	0.00025	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisone—atopic dermatitis	5.74e-05	0.000248	CcSEcCtD
Cyclophosphamide—Asthenia—Hydrocortisone—atopic dermatitis	5.73e-05	0.000247	CcSEcCtD
Cyclophosphamide—Anorexia—Prednisone—atopic dermatitis	5.66e-05	0.000244	CcSEcCtD
Cyclophosphamide—Pruritus—Hydrocortisone—atopic dermatitis	5.65e-05	0.000244	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Betamethasone—atopic dermatitis	5.62e-05	0.000243	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Dexamethasone—atopic dermatitis	5.62e-05	0.000243	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Triamcinolone—atopic dermatitis	5.54e-05	0.000239	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Methylprednisolone—atopic dermatitis	5.53e-05	0.000239	CcSEcCtD
Cyclophosphamide—Diarrhoea—Hydrocortisone—atopic dermatitis	5.46e-05	0.000236	CcSEcCtD
Cyclophosphamide—Urticaria—Betamethasone—atopic dermatitis	5.42e-05	0.000234	CcSEcCtD
Cyclophosphamide—Urticaria—Dexamethasone—atopic dermatitis	5.42e-05	0.000234	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Prednisone—atopic dermatitis	5.41e-05	0.000234	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisolone—atopic dermatitis	5.41e-05	0.000233	CcSEcCtD
Cyclophosphamide—Asthenia—Triamcinolone—atopic dermatitis	5.4e-05	0.000233	CcSEcCtD
Cyclophosphamide—Body temperature increased—Betamethasone—atopic dermatitis	5.39e-05	0.000233	CcSEcCtD
Cyclophosphamide—Body temperature increased—Dexamethasone—atopic dermatitis	5.39e-05	0.000233	CcSEcCtD
Cyclophosphamide—Asthenia—Methylprednisolone—atopic dermatitis	5.38e-05	0.000232	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisone—atopic dermatitis	5.34e-05	0.00023	CcSEcCtD
Cyclophosphamide—Pruritus—Triamcinolone—atopic dermatitis	5.32e-05	0.00023	CcSEcCtD
Cyclophosphamide—Pruritus—Methylprednisolone—atopic dermatitis	5.31e-05	0.000229	CcSEcCtD
Cyclophosphamide—Dizziness—Hydrocortisone—atopic dermatitis	5.28e-05	0.000228	CcSEcCtD
Cyclophosphamide—Decreased appetite—Prednisone—atopic dermatitis	5.17e-05	0.000223	CcSEcCtD
Cyclophosphamide—Rash—Prednisolone—atopic dermatitis	5.16e-05	0.000223	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisolone—atopic dermatitis	5.15e-05	0.000222	CcSEcCtD
Cyclophosphamide—Diarrhoea—Methylprednisolone—atopic dermatitis	5.13e-05	0.000222	CcSEcCtD
Cyclophosphamide—Fatigue—Prednisone—atopic dermatitis	5.12e-05	0.000221	CcSEcCtD
Cyclophosphamide—Headache—Prednisolone—atopic dermatitis	5.12e-05	0.000221	CcSEcCtD
Cyclophosphamide—Constipation—Prednisone—atopic dermatitis	5.08e-05	0.000219	CcSEcCtD
Cyclophosphamide—Vomiting—Hydrocortisone—atopic dermatitis	5.08e-05	0.000219	CcSEcCtD
Cyclophosphamide—Rash—Hydrocortisone—atopic dermatitis	5.04e-05	0.000217	CcSEcCtD
Cyclophosphamide—Dermatitis—Hydrocortisone—atopic dermatitis	5.03e-05	0.000217	CcSEcCtD
Cyclophosphamide—Headache—Hydrocortisone—atopic dermatitis	5e-05	0.000216	CcSEcCtD
Cyclophosphamide—Dizziness—Triamcinolone—atopic dermatitis	4.97e-05	0.000215	CcSEcCtD
Cyclophosphamide—Dizziness—Methylprednisolone—atopic dermatitis	4.96e-05	0.000214	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisone—atopic dermatitis	4.9e-05	0.000211	CcSEcCtD
Cyclophosphamide—Asthenia—Dexamethasone—atopic dermatitis	4.9e-05	0.000211	CcSEcCtD
Cyclophosphamide—Asthenia—Betamethasone—atopic dermatitis	4.9e-05	0.000211	CcSEcCtD
Cyclophosphamide—Nausea—Prednisolone—atopic dermatitis	4.86e-05	0.00021	CcSEcCtD
Cyclophosphamide—Pruritus—Dexamethasone—atopic dermatitis	4.83e-05	0.000208	CcSEcCtD
Cyclophosphamide—Pruritus—Betamethasone—atopic dermatitis	4.83e-05	0.000208	CcSEcCtD
Cyclophosphamide—Vomiting—Triamcinolone—atopic dermatitis	4.78e-05	0.000206	CcSEcCtD
Cyclophosphamide—Vomiting—Methylprednisolone—atopic dermatitis	4.77e-05	0.000206	CcSEcCtD
Cyclophosphamide—Nausea—Hydrocortisone—atopic dermatitis	4.74e-05	0.000205	CcSEcCtD
Cyclophosphamide—Rash—Triamcinolone—atopic dermatitis	4.74e-05	0.000205	CcSEcCtD
Cyclophosphamide—Dermatitis—Triamcinolone—atopic dermatitis	4.74e-05	0.000204	CcSEcCtD
Cyclophosphamide—Rash—Methylprednisolone—atopic dermatitis	4.73e-05	0.000204	CcSEcCtD
Cyclophosphamide—Dermatitis—Methylprednisolone—atopic dermatitis	4.73e-05	0.000204	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisone—atopic dermatitis	4.72e-05	0.000204	CcSEcCtD
Cyclophosphamide—Headache—Triamcinolone—atopic dermatitis	4.71e-05	0.000203	CcSEcCtD
Cyclophosphamide—Headache—Methylprednisolone—atopic dermatitis	4.7e-05	0.000203	CcSEcCtD
Cyclophosphamide—Body temperature increased—Prednisone—atopic dermatitis	4.7e-05	0.000203	CcSEcCtD
Cyclophosphamide—Diarrhoea—Betamethasone—atopic dermatitis	4.67e-05	0.000201	CcSEcCtD
Cyclophosphamide—Diarrhoea—Dexamethasone—atopic dermatitis	4.67e-05	0.000201	CcSEcCtD
Cyclophosphamide—Dizziness—Betamethasone—atopic dermatitis	4.51e-05	0.000195	CcSEcCtD
Cyclophosphamide—Dizziness—Dexamethasone—atopic dermatitis	4.51e-05	0.000195	CcSEcCtD
Cyclophosphamide—Nausea—Triamcinolone—atopic dermatitis	4.47e-05	0.000193	CcSEcCtD
Cyclophosphamide—Nausea—Methylprednisolone—atopic dermatitis	4.46e-05	0.000192	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisone—atopic dermatitis	4.38e-05	0.000189	CcSEcCtD
Cyclophosphamide—Vomiting—Betamethasone—atopic dermatitis	4.34e-05	0.000187	CcSEcCtD
Cyclophosphamide—Vomiting—Dexamethasone—atopic dermatitis	4.34e-05	0.000187	CcSEcCtD
Cyclophosphamide—Rash—Dexamethasone—atopic dermatitis	4.3e-05	0.000186	CcSEcCtD
Cyclophosphamide—Rash—Betamethasone—atopic dermatitis	4.3e-05	0.000186	CcSEcCtD
Cyclophosphamide—Dermatitis—Betamethasone—atopic dermatitis	4.3e-05	0.000186	CcSEcCtD
Cyclophosphamide—Dermatitis—Dexamethasone—atopic dermatitis	4.3e-05	0.000186	CcSEcCtD
Cyclophosphamide—Headache—Betamethasone—atopic dermatitis	4.27e-05	0.000184	CcSEcCtD
Cyclophosphamide—Headache—Dexamethasone—atopic dermatitis	4.27e-05	0.000184	CcSEcCtD
Cyclophosphamide—Asthenia—Prednisone—atopic dermatitis	4.26e-05	0.000184	CcSEcCtD
Cyclophosphamide—Pruritus—Prednisone—atopic dermatitis	4.2e-05	0.000181	CcSEcCtD
Cyclophosphamide—Diarrhoea—Prednisone—atopic dermatitis	4.07e-05	0.000175	CcSEcCtD
Cyclophosphamide—Nausea—Dexamethasone—atopic dermatitis	4.05e-05	0.000175	CcSEcCtD
Cyclophosphamide—Nausea—Betamethasone—atopic dermatitis	4.05e-05	0.000175	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisone—atopic dermatitis	3.93e-05	0.00017	CcSEcCtD
Cyclophosphamide—Vomiting—Prednisone—atopic dermatitis	3.78e-05	0.000163	CcSEcCtD
Cyclophosphamide—Rash—Prednisone—atopic dermatitis	3.75e-05	0.000162	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisone—atopic dermatitis	3.74e-05	0.000162	CcSEcCtD
Cyclophosphamide—Headache—Prednisone—atopic dermatitis	3.72e-05	0.000161	CcSEcCtD
Cyclophosphamide—Nausea—Prednisone—atopic dermatitis	3.53e-05	0.000152	CcSEcCtD
